PMCB
#4909
PharmaCyte Biotech, Inc. - Common Stock
0.5 2 USD
-0.04%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-3.70%
Monthly Change
-11.86%
6 month change
-23.53%
Year Change
-48.00%
Previous Close
0.5 4
Open
0.5 1
Low
0.5 0
High
0.5 2
Volume
13
Financials
- Market Capitalization 5.58 M
- Employee 2
- Founded 1996
- CEO N/A
- Website pharmacyte.com
- Headquarter Nevada, United States
- FIGI BBG000BBVY94
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4900 |  LIMN Liminatus Pharma, Inc. - Class A Common Stock | 4.23 USD | -3.86% | -16.07% | +3745.45% | +43.39% | 5.68 M USD | ||
| 4901 |  BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.18 USD | -75.00% | -77.50% | -77.22% | -88.61% | 5.63 M USD | ||
| 4912 |  CVKD Cadrenal Therapeutics, Inc. - Common Stock | 1.54 USD | -1.91% | -8.88% | -23.38% | -72.10% | 5.49 M USD | ||
| 4913 |  CDIO Cardio Diagnostics Holdings Inc. - Common stock | 1.85 USD | 0.00% | -4.15% | +18.59% | -29.52% | 5.48 M USD |
Frequently asked questions about PharmaCyte Biotech, Inc. Common Stock
What is the PharmaCyte Biotech, Inc. Common Stock stock price today?
The current price of PharmaCyte Biotech, Inc. Common Stock (PMCB) is 0.52. Over the past 24 hours, the stock has changed by -3.70%. Follow the PMCB chart for real-time price dynamics.
What is the stock ticker of PharmaCyte Biotech, Inc. Common Stock?
PharmaCyte Biotech, Inc. Common Stock trades under the ticker PMCB. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is PharmaCyte Biotech, Inc. Common Stock stock going up?
PMCB has changed by -1.89% over the last week, -11.86% over the last month, and -48.00% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of PharmaCyte Biotech, Inc. Common Stock?
PharmaCyte Biotech, Inc. Common Stock currently has a market capitalization of 5.58 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were PharmaCyte Biotech, Inc. Common Stock earnings last quarter?
Last quarter, PharmaCyte Biotech, Inc. Common Stock reported earnings of -0.13 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was PharmaCyte Biotech, Inc. Common Stock revenue for the last quarter?
PharmaCyte Biotech, Inc. Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was PharmaCyte Biotech, Inc. Common Stock net income for the last quarter?
PharmaCyte Biotech, Inc. Common Stock reported net income of -4.39 M for the last quarter. The previous quarter showed 746.86 K, which means net income changed by -688.26%.
How many employees does PharmaCyte Biotech, Inc. Common Stock have?
As of the latest available data, PharmaCyte Biotech, Inc. Common Stock has 2 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy PharmaCyte Biotech, Inc. Common Stock stock?
You can buy PharmaCyte Biotech, Inc. Common Stock (PMCB) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in PharmaCyte Biotech, Inc. Common Stock stock?
Investing in PharmaCyte Biotech, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PMCB chart and related analysis on metatrader.com as part of your research.